Antares Pharma Announces Filing of New Drug Application for Anturol for Overactive Bladder
Links shared publicly online about this topic.
- 614total visits
Antares Pharma Announces Filing of New Drug Application for Anturol for Overactive Bladder
Anturol (oxybutynin) is a new drug in development for the treatment of overactive bladder. Anturol information includes news, clinical trial results and side effects.
View full resource at drugs.com
Tags: Urinary System, Overactive Bladder, Overactive Bladder Medication, Drug, Pharma, Ditropan, Bladder Dysfunction
Most Recently Shared on December 31, 2010 at 10:15 pm By:
Antares Pharma Announces Filing of New Drug Application for Anturol for Overactive Bladder: EWING, N.J.--(... http://bit.ly/hVagOP #drug
Antares Pharma Announces FDA Acceptance of Anturol NDA for Filing
drugs.com — “Anturol (oxybutynin) is a new drug in development for the treatment of overactive bladder. Anturol information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 5, 2011 at 12:15 am By:
Drugs and Devices OW OW Health
Antares Pharma Announces FDA Acceptance of Anturol NDA for Filing: EWING, N.J.--(BUSINESS WIRE)--Apr 8, 20... http://bit.ly/iE4oV3 #drug
Advertisement
